Showing results (1-10 of 141) with videos related to
Sort By:
Pageof 15
Shock (Augusta, Ga.)|June 19, 2003
A meta-analysis of controlled trials of anticoagulant therapies in patients with sepsisBradley D Freeman, Barbara A Zehnbauer, Timothy G BuchmanCritical Care Medicine|October 1, 2009
Association between lymphotoxin-alpha (tumor necrosis factor-beta) intron polymorphism and predisposition to severe sepsis is modified by gender and ageEizo Watanabe, Timothy G Buchman, Hiroyuki Hirasawa, et al.The Journal of Molecular Diagnostics : JMD|November 2, 2002
Template-directed dye-terminator incorporation with fluorescence polarization detection for analysis of single nucleotide polymorphisms implicated in sepsisBradley D Freeman, Timothy G Buchman, Sean McGrath, et al.Cytokine|July 4, 2012
Tumor necrosis factor -308 polymorphism (rs1800629) is associated with mortality and ventilator duration in 1057 Caucasian patientsEizo Watanabe, Barbara A Zehnbauer, Shigeto Oda, et al.Critical Care Medicine|February 18, 2006
Genetic research and testing in critical care: surrogates' perspectiveBradley D Freeman, Carie R Kennedy, Craig M Coopersmith, et al.Pharmacoepidemiology and Drug Safety|August 12, 2008
Pharmacoepidemiology of QT-interval prolonging drug administration in critically ill patientsBradley D Freeman, David J Dixon, Craig M Coopersmith, et al.Journal of the American College of Surgeons|March 15, 2002
The frequency and effects of cytochrome P450 (CYP) 2C9 polymorphisms in patients receiving warfarinArash Rafii Tabrizi, Barbara A Zehnbauer, Ingrid B Borecki, et al.The Journal of Molecular Diagnostics : JMD|October 23, 2019
The Journal of Molecular Diagnostics: 20 Years Defining Professional PracticeBarbara A ZehnbauerThe Journal of Molecular Diagnostics : JMD|December 23, 2019
Renewed Commitments to Key PartnersBarbara A ZehnbauerThe Journal of Molecular Diagnostics : JMD|June 5, 2020
Economics of Coding, Coverage, and Reimbursement for Molecular DiagnosticsBarbara A ZehnbauerPageof 15